S001 Technology in Dermatology: Tailoring Solutions to Your Practice and Optimizing Joy & Impact
DESCRIPTION
This session aims to showcase technology solutions to clinical and operational problems relevant to providers and patients. Optimizing the use of electronic health records (EHRs), telehealth, augmented intelligence (AuI), and smartphone apps will be discussed so attendees can evaluate opportunities for digital transformation, and not just digitization, in their practices. The pandemic highlighted the value of digital tools such as telehealth and elucidated the immense potential for customization and integration of these technological tools to provide high-quality, accessible, and equitable care for all patients if we design for it. The relevant clinical needs and the proposed technological solutions will be presented and evaluated with a lens toward usability, inclusivity, equity, and meaningful impact on patients and providers. The challenging potential of burden versus benefit of technological tools on physician burnout will also be discussed.
LEARNING OBJECTIVES
Identify greatest unmet needs for clinicians and patients and couple them with existing technological solutions with the aim of optimizing professional fulfillment and reducing burnout
Discuss evidence-based clinical guidelines and regulatory updates on telehealth and best practices for workflow integration
Describe advances in augmented intelligence and real-world applications Share EHR customization tools and resources for more efficient and effective documentation and data collection
SCHEDULE
9:00 AM
Introduction
Trilokraj Tejasvi, MD, MBBS
9:05 AM
Hybrid teledermatology
Trilokraj Tejasvi, MD, MBBS
9:20 AM
Apps in Dermatology
George Han, MD, PhD, FAAD
9:40 AM
EHRs
Meenal Kheterpal, MD, FAAD
10:00 AM
Non invasive Imaging
Babar K. Rao, MD, FAAD
10:20 AM
AuI
Veronica Rotemberg, MD, FAAD
10:40 AM
Digital Divide
Jules Lipoff, MD, FAAD
11:00 AM
Panel discussion Q&A
DIRECTOR
Trilokraj Tejasvi, MD, MBBS
SPEAKERS
George Han, MD, PhD, FAAD
Meenal Kheterpal, MD, FAAD
Jules Lipoff, MD, FAAD
Babar K. Rao, MD, FAAD
Veronica Rotemberg, MD, FAAD
DISCLOSURES
George Han, MD, PhD, FAAD
AbbVie – Speaker(Honoraria); Amgen – Advisory Board(Honoraria); Avillion – Investigator(Grants/Research Funding); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria); Castle Biosciences – Advisory Board(Honoraria); Celgene – Investigator(Grants/Research Funding); DermTech Inc. – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Hikma Pharmaceuticals – Speaker/Faculty Education(Honoraria); Incyte Corporation – Advisory Board(Honoraria), Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); MC2 Therapeutics – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Investigator(Grants/Research Funding); Othro Dermatologics – Advisory Board(Honoraria); Pfizer Inc. – Speaker(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria); Sanofi Genzyme – Speaker(Honoraria); Sonoma Pharmaceuticals – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Speaker(Honoraria); UCB – Advisory Board(Honoraria);
Meenal Kheterpal, MD, FAAD
LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Fees); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); RewindingRx – Board of Directors(Fees); Skintelligent – Advisory Board(No Compensation Received); Spectrum – Consultant(Fees); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees), Speaker(Fees); Teladoc Health, Inc. – Consultant(Fees); US Department of Justice – Consultant(Fees);
Jules Lipoff, MD, FAAD
Amgen – Consultant (1099 relationship)(Fees); Guidepoint Global, LLC – Consultant(Fees); Pfizer Inc. – Investigator(Grants/Research Funding); Springer Science & Business Media – Other(Patent royalties or other compensation for Intellectual Property Rights); Takeda Pharmaceuticals USA Inc – Advisory Board(Fees); UpToDate – Other(Other Financial Benefit);
Babar K. Rao, MD, FAAD
No financial relationships exist with ineligible companies.
Veronica Rotemberg, MD, FAAD
Amazon Web Services – Investigator(Grants/Research Funding); Atria Institute – Consultant (1099 relationship)(Other Financial Benefit); Inhabit Brands – Advisory Board(Stock); Johnson and Johnson – Stockholder(No Compensation Received); Kaggle (Google) – Investigator(Grants/Research Funding);
Trilokraj Tejasvi, MD, MBBS
No financial relationships exist with ineligible companies.